Related Experiment Video
Updated: Sep 24, 2026

Gastrointestinal Motility Monitor (GIMM)
Published on: December 2, 2010
Severe gastrointestinal dysmotility in autoimmune autonomic ganglionopathy: recognition, reclassification and
Julian Leto1, Belinda Errington2, Katharine Kline3
1Immunology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia julian.leto@health.nsw.gov.au.
Abstract:
A 30-year-old woman presented with sepsis. She had chronic severe gastrointestinal dysmotility and depended on parenteral nutrition. Further history identified orthostatic intolerance, hypohidrosis and recurrent opioid-induced respiratory depression. She was noted incidentally to have tonic pupils; applying topical apraclonidine and dilute pilocarpine eye drops demonstrated both sympathetic and parasympathetic pupil denervation. Serum testing identified antibodies against the ganglionic nicotinic acetylcholine receptor, consistent with autoimmune autonomic ganglionopathy. After treatment with plasma exchange and pulsed intravenous cyclophosphamide, all features of autonomic dysfunction had improved by 3 months. Parenteral nutrition was soon stopped completely, and at 12 months, she had sustained remission of all symptoms of autonomic dysfunction while taking maintenance immunosuppression with mycophenolic acid. Accurate diagnosis of autoimmune autonomic ganglionopathy can allow functional cure of chronic severe gastrointestinal dysmotility with appropriate immunosuppression. Neurologists and non-neurologists should be aware of this condition.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Drugs Acting on Autonomic Ganglia: Blockers
Gastrointestinal Motility Disorders
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Myasthenia Gravis ll: Pathophysiology

